205 related articles for article (PubMed ID: 24404147)
1. DEC1 coordinates with HDAC8 to differentially regulate TAp73 and ΔNp73 expression.
Qian Y; Zhang J; Jung YS; Chen X
PLoS One; 2014; 9(1):e84015. PubMed ID: 24404147
[TBL] [Abstract][Full Text] [Related]
2. TAp73 and ΔNp73 have opposing roles in 5-aza-2'-deoxycytidine-induced apoptosis in breast cancer cells.
Lai J; Yang F; Zhang W; Wang Y; Xu J; Song W; Huang G; Gu J; Guan X
Mol Cells; 2014 Aug; 37(8):605-12. PubMed ID: 25134538
[TBL] [Abstract][Full Text] [Related]
3. Spatiotemporal switch from DeltaNp73 to TAp73 isoforms during nephrogenesis: impact on differentiation gene expression.
Saifudeen Z; Diavolitsis V; Stefkova J; Dipp S; Fan H; El-Dahr SS
J Biol Chem; 2005 Jun; 280(24):23094-102. PubMed ID: 15805112
[TBL] [Abstract][Full Text] [Related]
4. Differential control of TAp73 and DeltaNp73 protein stability by the ring finger ubiquitin ligase PIR2.
Sayan BS; Yang AL; Conforti F; Tucci P; Piro MC; Browne GJ; Agostini M; Bernardini S; Knight RA; Mak TW; Melino G
Proc Natl Acad Sci U S A; 2010 Jul; 107(29):12877-82. PubMed ID: 20615966
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of the p73 gene by Nrf-2 and promoter CpG methylation in human breast cancer.
Lai J; Nie W; Zhang W; Wang Y; Xie R; Wang Y; Gu J; Xu J; Song W; Yang F; Huang G; Cao P; Guan X
Oncotarget; 2014 Aug; 5(16):6909-22. PubMed ID: 25071010
[TBL] [Abstract][Full Text] [Related]
6. Mdm2-mediated NEDD8 modification of TAp73 regulates its transactivation function.
Watson IR; Blanch A; Lin DC; Ohh M; Irwin MS
J Biol Chem; 2006 Nov; 281(45):34096-103. PubMed ID: 16980297
[TBL] [Abstract][Full Text] [Related]
7. DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors.
Zaika AI; Slade N; Erster SH; Sansome C; Joseph TW; Pearl M; Chalas E; Moll UM
J Exp Med; 2002 Sep; 196(6):765-80. PubMed ID: 12235210
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the ∆Np73 isoform is associated with centrosome amplification in brain tumor cell lines.
Mikulenkova E; Neradil J; Zitterbart K; Sterba J; Veselska R
Tumour Biol; 2015 Sep; 36(10):7483-91. PubMed ID: 25910708
[TBL] [Abstract][Full Text] [Related]
9. Involvement of N-terminally truncated variants of p73, deltaTAp73, in head and neck squamous cell cancer: a comparison with p53 mutations.
Faridoni-Laurens L; Tourpin S; Alsafadi S; Barrois M; Temam S; Janot F; Koscielny S; Bosq J; Bénard J; Ahomadegbe JC
Cell Cycle; 2008 Jun; 7(11):1587-96. PubMed ID: 18469517
[TBL] [Abstract][Full Text] [Related]
10. DeltaNp73 modulates nerve growth factor-mediated neuronal differentiation through repression of TrkA.
Zhang J; Chen X
Mol Cell Biol; 2007 May; 27(10):3868-80. PubMed ID: 17353261
[TBL] [Abstract][Full Text] [Related]
11. TAp73 protein stability is controlled by histone deacetylase 1 via regulation of Hsp90 chaperone function.
Zhang J; Xu E; Chen X
J Biol Chem; 2013 Mar; 288(11):7727-7737. PubMed ID: 23362263
[TBL] [Abstract][Full Text] [Related]
12. TAp73/Delta Np73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma.
Müller M; Schilling T; Sayan AE; Kairat A; Lorenz K; Schulze-Bergkamen H; Oren M; Koch A; Tannapfel A; Stremmel W; Melino G; Krammer PH
Cell Death Differ; 2005 Dec; 12(12):1564-77. PubMed ID: 16195739
[TBL] [Abstract][Full Text] [Related]
13. Relative expression of TAp73 and ΔNp73 isoforms.
Conforti F; Yang AL; Agostini M; Rufini A; Tucci P; Nicklison-Chirou MV; Grespi F; Velletri T; Knight RA; Melino G; Sayan BS
Aging (Albany NY); 2012 Mar; 4(3):202-5. PubMed ID: 22388545
[TBL] [Abstract][Full Text] [Related]
14. DeltaNp73 antisense activates PUMA and induces apoptosis in neuroblastoma cells.
Simões-Wüst AP; Sigrist B; Belyanskaya L; Hopkins Donaldson S; Stahel RA; Zangemeister-Wittke U
J Neurooncol; 2005 Mar; 72(1):29-34. PubMed ID: 15803372
[TBL] [Abstract][Full Text] [Related]
15. Disruption of chromosomal locus 1p36 differentially modulates TAp73 and ΔNp73 expression in follicular lymphoma.
Hassan HM; Varney ML; Jain S; Weisenburger DD; Singh RK; Dave BJ
Leuk Lymphoma; 2014 Dec; 55(12):2924-31. PubMed ID: 24660851
[TBL] [Abstract][Full Text] [Related]
16. Negative autoregulation of p73 and p53 by DeltaNp73 in regulating differentiation and survival of human neuroblastoma cells.
Nakagawa T; Takahashi M; Ozaki T; Watanabe K; Hayashi S; Hosoda M; Todo S; Nakagawara A
Cancer Lett; 2003 Jul; 197(1-2):105-9. PubMed ID: 12880968
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase inhibitors differentially modulate p73 isoforms in neuroblastoma.
Lau LM; Wolter JK; Lau JT; Cheng LS; Smith KM; Hansford LM; Zhang L; Baruchel S; Robinson F; Irwin MS
Oncogene; 2009 May; 28(19):2024-33. PubMed ID: 19363520
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of p63 and p73 expression.
Waltermann A; Kartasheva NN; Dobbelstein M
Oncogene; 2003 Aug; 22(36):5686-93. PubMed ID: 12944917
[TBL] [Abstract][Full Text] [Related]
19. Possible oncogenic potential of DeltaNp73: a newly identified isoform of human p73.
Ishimoto O; Kawahara C; Enjo K; Obinata M; Nukiwa T; Ikawa S
Cancer Res; 2002 Feb; 62(3):636-41. PubMed ID: 11830511
[TBL] [Abstract][Full Text] [Related]
20. The presence of an intronic deletion in p73 and high levels of ZEB1 alter the TAp73/DeltaTAp73 ratio in colorectal carcinomas.
Domínguez G; Peña C; Silva J; García JM; García V; Rodríguez R; Cantos B; Citores MJ; España P; Bonilla F
J Pathol; 2006 Dec; 210(4):390-7. PubMed ID: 17029218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
